Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:433-434
doi: 10.1161/01.ATV.0000198249.67996.e0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janket, S.-J.
Right arrow Articles by Jones, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janket, S.-J.
Right arrow Articles by Jones, J. A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:433.)
© 2006 American Heart Association, Inc.


Letters to the Editor

Letter to the Editor

Salivary Lysozyme and Prevalent Coronary Heart Disease. Possible Effects of Oral Health on Endothelial Dysfunction

Sok-Ja Janket; Jukka H. Meurman; Pekka Nuutinen; Markku Qvarnström; Martha E. Nunn; Alison E. Baird; Thomas E. Van Dyke; Judith A. Jones

From the Boston University School of Dental Medicine (S.-J.J., M.E.N., T.E.V.D., J.A.J.), Boston, Mass; the University of Helsinki Dental School (J.H.M., M.Q.), Helsinki, Finland; the Kuopio University Medical School (P.N.), Finland; and the National Institute of Neurological Disorders and Stroke (A.E.B.), National Institutes of Health, Bethesda, Maryland.

Correspondence to Sok-Ja Janket, Boston University School of Dental Medicine, 100 East Newton St, Rm G-619, Boston, MA 02118. E-mail skjanket@bu.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Total leukocyte count in the peripheral blood has been reported to be a significant predictor of future cardiac events and mortality.1 Leukocyte-derived salivary lysozyme has been associated with oral infection,2 and serum lysozyme has been implicated in impaired glucose metabolism,3 a contributory factor for endothelial dysfunction.4 We postulated that salivary lysozyme, therefore, would be associated with coronary heart disease (CHD).

This study was approved by the joint ethical committee of the Kuopio University Hospital and the University of Kuopio. We investigated the relationship between the CHD and lysozyme levels in a case-control study of 250 angiographically confirmed CHD patients and 250 sex- and age-matched controls, adjusting for age, sex, smoking, body mass index (BMI), diabetes mellitus, total cholesterol/high-density lipoprotein (HDL) cholesterol, hyperten sion, and serum C-reactive protein (CRP) levels ≥10 mg/L or ≥3 mg/L using logistic regression analyses. To assess the specific contribution of oral health through impaired glucose metabolism, we controlled for the Asymptotic Dental Score (ADS), an estimate of oral infection burden, comprising 5 major oral pathologies, namely pericoronitis, gingivitis, dental caries, root remnants, and the edentulous state.5

The basic characteristics of the cohort (Table I, available online at http://atvb.ahajournals.org) and cross-tabulation of lysozyme levels and other vascular risk factors are presented online (Table II, available online at http://atvb.ahajournals.org). After adjustment for established cardiac risk factors including age, sex, smoking, total cholesterol/HDL cholesterol, diabetes, hypertension, BMI, and CRP, odds ratios (ORs) with 95% CIs for the association between salivary lysozyme and CHD increased from 1.00 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
JDRHome page
M. Qvarnstrom, S. Janket, J.A. Jones, P. Nuutinen, A.E. Baird, M.E. Nunn, T.E. Van Dyke, and J.H. Meurman
Salivary Lysozyme and Prevalent Hypertension
Journal of Dental Research, May 1, 2008; 87(5): 480 - 484.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
T. Watts, S.-J. Janket, T. E. Van Dyke, and J. A. Jones
Periodontal Treatment and Glycemic Control in Diabetic Patients: the Problem of a Possible Hawthorne Effect
Journal of Dental Research, April 1, 2006; 85(4): 294 - 295.
[Full Text] [PDF]